Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine for Apnea of Prematurity
NCT00182312Phase 3Completed
- Sponsor
- McMaster University
- Start
- Oct 1999
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 9
01
Overview
Phase 3, randomised, double-blind trial in apnea of prematurity (AOP) comparing Caffeine Citrate with Placebo (2 arms). Primary endpoint: Combined rate of mortality and neurodevelopmental disability. Started Oct 1999; status: completed.
02
Drugs
caffeine
03
Conditions
apnea of prematurity (AOP)
Beyond the preview
Go deeper on NCT00182312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182312.